156 related articles for article (PubMed ID: 29653819)
1. Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.
Shukla ND; Salahudeen AA; Taylor GA; Ramalingam SS; Vokes EE; Goss GD; Decker RH; Kelly K; Scagliotti GV; Mok TS; Wakelee HA
Clin Lung Cancer; 2018 Sep; 19(5):377-386. PubMed ID: 29653819
[TBL] [Abstract][Full Text] [Related]
2. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
Salahudeen AA; Patel MI; Baas P; Curran WJ; Bradley JD; Gandara DR; Goss GD; Mok TS; Ramalingam SS; Vokes EE; Malik SM; Wakelee HA
Clin Lung Cancer; 2017 Jan; 18(1):5-12. PubMed ID: 27473736
[TBL] [Abstract][Full Text] [Related]
3. Summary of current cooperative group clinical trials in thoracic malignancies. The Thoracic Intergroup.
Rusch VW; Feins RH
Ann Thorac Surg; 1994 Jan; 57(1):102-6. PubMed ID: 8279873
[TBL] [Abstract][Full Text] [Related]
4. Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer.
Wakelee H; Kernstine K; Vokes E; Schiller J; Baas P; Saijo N; Adjei A; Goss G; Gaspar L; Gandara DR; Choy H; Putnam JB
Clin Lung Cancer; 2008 Nov; 9(6):346-51. PubMed ID: 19073517
[TBL] [Abstract][Full Text] [Related]
5. Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress.
Wakelee H; Loo BW; Kernstine KH; Putnam JB; Edelman MJ; Vokes EE; Schiller JH; Baas P; Saijo N; Adjei A; Goss G; Choy H; Gandara DR
Clin Lung Cancer; 2009 Nov; 10(6):395-404. PubMed ID: 19900856
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies.
Kiesgen S; Chicaybam L; Chintala NK; Adusumilli PS
J Thorac Oncol; 2018 Jan; 13(1):16-26. PubMed ID: 29107016
[TBL] [Abstract][Full Text] [Related]
7. Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC.
Facchinetti F; Marabelle A; Rossi G; Soria JC; Besse B; Tiseo M
J Thorac Oncol; 2016 Nov; 11(11):1819-1836. PubMed ID: 27288978
[TBL] [Abstract][Full Text] [Related]
8. Tumor antigens in thoracic malignancy.
Dubinett SM; Batra RK; Miller PW; Sharma S
Am J Respir Cell Mol Biol; 2000 May; 22(5):524-7. PubMed ID: 10783122
[No Abstract] [Full Text] [Related]
9. Photodynamic Therapy in Non-Gastrointestinal Thoracic Malignancies.
Kidane B; Hirpara D; Yasufuku K
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805818
[TBL] [Abstract][Full Text] [Related]
10. Cooperative trials in thoracic oncology are important.
Benfield JR
Ann Thorac Surg; 1994 Jan; 57(1):10-1. PubMed ID: 8279872
[No Abstract] [Full Text] [Related]
11. Pembrolizumab for the treatment of thoracic malignancies: current landscape and future directions.
Karim S; Leighl N
Future Oncol; 2016 Jan; 12(1):9-23. PubMed ID: 26631501
[TBL] [Abstract][Full Text] [Related]
12. Cooperative group research endeavors in small-cell lung cancer: current and future directions.
Sangha R; Lara PN; Adjei AA; Baas P; Choy H; Gaspar LE; Goss G; Saijo N; Schiller JH; Vokes EE; Gandara DR
Clin Lung Cancer; 2009 Sep; 10(5):322-30. PubMed ID: 19808190
[TBL] [Abstract][Full Text] [Related]
13. Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist.
Nicholson AG; Tsao MS; Travis WD; Patil DT; Galateau-Salle F; Marino M; Dacic S; Beasley MB; Butnor KJ; Yatabe Y; Pass HI; Rusch VW; Detterbeck FC; Asamura H; Rice TW; Rami-Porta R
Arch Pathol Lab Med; 2018 May; 142(5):645-661. PubMed ID: 29480761
[TBL] [Abstract][Full Text] [Related]
14. [18F]Fluorodeoxyglucose PET in Thoracic Malignancies.
Vilstrup MH; Torigian DA
PET Clin; 2014 Oct; 9(4):391-420, v. PubMed ID: 26050944
[TBL] [Abstract][Full Text] [Related]
15. The International Thymic Malignancy Interest Group thymic initiative: a state-of-the-art study of thymic malignancies.
Detterbeck F; Korst R
Semin Thorac Cardiovasc Surg; 2014; 26(4):317-22. PubMed ID: 25837546
[TBL] [Abstract][Full Text] [Related]
16. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax.
Tafra L; Dale PS; Wanek LA; Ramming KP; Morton DL
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):119-28; discussion 129. PubMed ID: 7609535
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine kinase inhibitor cediranib for non-small cell lung cancer and other thoracic malignancies.
Nikolinakos P; Heymach JV
J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S131-4. PubMed ID: 18520296
[TBL] [Abstract][Full Text] [Related]
18. Emerging Therapies in Thoracic Malignancies.
Pawlik TM
Surg Oncol Clin N Am; 2020 Oct; 29(4):xiii-xiv. PubMed ID: 32883467
[No Abstract] [Full Text] [Related]
19. [Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers].
Duruisseaux M; Rouquette I; Adam J; Cortot A; Cazes A; Gibault L; Damotte D; Lantuejoul S
Ann Pathol; 2017 Feb; 37(1):61-78. PubMed ID: 28162296
[TBL] [Abstract][Full Text] [Related]
20. I-O Optimise: a novel multinational real-world research platform in thoracic malignancies.
Ekman S; Griesinger F; Baas P; Chao D; Chouaid C; O'Donnell JC; Penrod JR; Daumont M; Lacoin L; McKenney A; Khovratovich M; Munro RE; Durand-Zaleski I; Johnsen SP
Future Oncol; 2019 May; 15(14):1551-1563. PubMed ID: 30852916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
